Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerAimery de Gramont, Andrea Bonetti, Abdel Hmissi et al.|Journal of Clinical Oncology|2000Cited by 3.8k
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Paulo M. Hoff, Eric Van Cutsem et al.|The Lancet Oncology|2012Cited by 526
Fluoropyrimidine (FP) + bevacizumab (BEV) + atezolizumab vs FP/BEV in BRAFwt metastatic colorectal cancer (mCRC): Findings from Cohort 2 of MODUL – a multicentre, randomized trial of biomarker-driven maintenance treatment following first-line induction therapyAxel Grothey, Hans‐Joachim Schmoll, Josep Tabernero et al.|Annals of Oncology|2018Cited by 103
Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backboneBengt Glimelius, Aimery de Gramont, Sebastian Stintzing et al.|Cancer Treatment Reviews|2021Cited by 98
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009Eric Van Cutsem, Josep Tabernero, M. Dicato et al.|Annals of Oncology|2010Cited by 80